Characterization of Tisagenlecleucel, an Anti-CD 19 CAR T Cell Product Manufactured Using T Cells from Patients with DLBCLTherese Choquette,Margit JeschkeMOLECULAR THERAPY(2019)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要